Ventripoint Diagnostics Ltd.
TSX VENTURE : VPT

Ventripoint Diagnostics Ltd.

August 07, 2014 08:29 ET

Ventripoint Diagnostics Provides Clarification Related to the June 23, 2014 News Release

SEATTLE, WASHINGTON--(Marketwired - Aug. 7, 2014) -

NOT TO BE RELEASED IN THE UNITED STATES

Ventripoint Diagnostics Ltd. (the "Corporation") (TSX VENTURE:VPT) wishes to clarify the news release dated June 23, 2014. In particular, on June 20, 2014, the Corporation completed its previously announced private placement ("Private Placement") of 25,576,426 Units ("Units") for gross proceeds of $2,046,114. Each Unit is comprised of one common share ("Common Share") and one half of one Common Share purchase warrant ("Warrant"). There will be no further tranches of the Private Placement. The Corporation has paid aggregate cash commissions of $88,039 plus 1,100,488 warrants (the "Agent's Warrants") each exercisable to purchase one Unit of the Corporation. The Agent's Warrants will expire 18 months from the closing date of the Private Placement.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Contact Information